Physician profile
Anna Yang
NPI 1659754000
$1,569.93
in general payments reported to CMS, 2019-2025
13 companies · $94.88 in 2025
The $94.88 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $787 · 2020: $172 · 2021: $118 · 2022: $123 · 2023: $260 · 2024: $15.04 · 2025: $94.88.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $370.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $369.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paragon 28, INC. | $629.94 | 2019-2025 | Mtp |
| Stryker Corporation | $257.76 | 2019-2025 | Citrefix, Css Cannulated Screw System, Prostep |
| Orthofix Medical, INC. | $221.44 | 2019-2025 | Physio-Stim, Spinal-Stim |
| Smith+Nephew, INC. | $141.86 | 2019-2021 | |
| Organogenesis INC. | $67.41 | 2019-2023 | Puraply |
| Zimmer Biomet Holdings, INC. | $63.96 | 2019-2020 | |
| Horizon Therapeutics Plc | $55.71 | 2019-2020 | |
| Misonix INC | $31.81 | 2021 | |
| Integra Lifesciences Corporation | $27.38 | 2020 | |
| Anika Therapeutics, INC. | $21.75 | 2023 | Tactoset |
| Kerecis Limited | $20.46 | 2020 | |
| Abbott Laboratories | $16.18 | 2019 | |
| Osiris Therapeutics INC. | $14.27 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anna Yang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.